Foghorn Therapeutics (FHTX) PT Lowered to $23 at Morgan Stanley
Get Alerts FHTX Hot Sheet
Price: $11.92 -2.38%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 8 | New: 31
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:

Today's Overall Ratings:
Up: 18 | Down: 8 | New: 31
Trade Now!
Join SI Premium – FREE
Morgan Stanley analyst Vikram Purohit lowered the price target on Foghorn Therapeutics (NASDAQ: FHTX) to $23.00 (from $24.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Salzgitter AG (SZG:GR) (SZGPY) PT Raised to EUR35 at Jefferies
- Tenaris S.A. (TEN:IM) (TS) PT Raised to EUR9 at Jefferies
- Macquarie Upgrades Bangkok Dusit (BDMS:TB) (BDULF) to Outperform
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!